Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer. uri icon

Overview

publication date

  • May 4, 2021

Identity

PubMed Central ID

  • PMC8096937

Scopus Document Identifier

  • 85105243847

Digital Object Identifier (DOI)

  • 10.1038/s41541-021-00332-5

PubMed ID

  • 33947868

Additional Document Info

volume

  • 6

issue

  • 1